[{"NetIncomeLossConverted_1_Q2_USD":-14106000.0,"NetIncomeLossConverted_2_Q2_USD":-14020000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":12085000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":12045000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":20909000.0,"EarningsPerShareDiluted_1_Q2_USD":-1.17,"EarningsPerShareDiluted_2_Q2_USD":-1.16,"StockholdersEquity_0_Q2_USD":191917000.0,"RevenuesConverted_1_Q2_USD":48625000.0,"RevenuesConverted_2_Q2_USD":103146000.0,"Assets_0_Q2_USD":480159000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":12085000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":12045000.0,"EarningsPerShareBasic_1_Q2_USD":-1.17,"EarningsPerShareBasic_2_Q2_USD":-1.16,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]